WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 5'4361 Child (under 5 years) mortality rate: 152

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 21'890  21'804  21'533  21'032  20'346  16'371  12'452  8'956 
Births 529  526  523  519  514  496  445  400 
Surviving infants 520  518  514  510  506  486  432  380 
Pop. less than 5 years 2'624  2'644  2'640  2'626  2'562  2'399  2'137  1'753 
Pop. less than 15 years 7'738  7'752  7'695  7'631  7'479  6'681  5'842  4'363 
Female 15-49 years 5'594  5'590  5'538  5'395  5'208  4'062  2'710  1'847 

Number of reported case

(Click for retrospective incidence data for Syrian Arab Republic (the))
Diphtheria 80  366 
Japanese encephalitis
Measles 13  13  26  22  19  146  535  1'478 
Mumps 52  95  145  144  561  7'780 
Pertussis 90  70  19  59  124  39  430 
Polio* 13  312 
Rubella 20 
Rubella (CRS)
Tetanus (neonatal) 15  55  91 
Tetanus (total) 13  17  71  244 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Syrian Arab Republic (the))
Vaccine year result method % card seen                                                
BCG 2008  93  PAPFAM   65.8  84  99*  100  100  99  100  92  35 
DTP1 2008  88  PAPFAM   65.8  79  97  100  99  98  93 
DTP3 2008  82  PAPFAM   65.8  64  91  99  99  98  97  91  13 
HepB_BD          83  98  100  100  99  100 
HepB3 2005  77  MICS   55.3  58  81  99  99  98  90 
Hib3          64  91  98 
JapEnc         
MCV 2008  82  PAPFAM   65.8  78  97  99  99  98  96  87  13 
MCV2          70  88  99  99  92 
PCV1         
PCV3         
Pol3 2008  81  PAPFAM   65.8  68  91  99  99  98  97  91  13 
Rota1         
Rota_last         
Rubella1          78  97 
TT2plus 1989  51  EPI   69.9  11  16  28  23  24  20  63 
PAB         
VAD1          78  59  90  99  98  94 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Syrian Arab Republic (the))
BCG 82  90  97  95  93  91  92  35 
DTP1 68  86  89  89  88  90  93  35 
DTP3 45  72  80  80  79  84  91  13 
HepB3 43  66  84  84  83  79 
Hib3 45  72  80  80  79 
MCV 61  80  82  82  81  84  87  13 
PAB 94  94  94  94  94  90  63 
PCV3
Pol3 52  75  83  83  83  86  91  13 
Rota_last

Number of districts in the country 75  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
89 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 100
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTwPHib 4, 18 months;
DTwPHibHepB 2, 6 months;
HepB birth; Yes
IPV 2, 4 months;
MMR 12, 18 months; Yes
MenACWY 6 years; Yes
OPV 6, 12, 18 months; Yes
TT 1st contact ; +1, +6 months; +1, +1 year; Yes
Td 12 years; Yes
VitaminA 12, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2012  2006-2011  2006-2010  2006-2010  2006-2010  2008-2010  2'010 
Nº of districts with microplans that include activities to raise immunization coverage number 75  75  75  71  71    71 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 75  75  75  71  71  71  71 
Nº districts with DTP3 coverage >=80% number   75  71  71     
% of districts with DTP3 coverage >=80% From 0 to 100%   100  100  100     
Nº districts with measles (MCV1) coverage >=95% number   75    63     
% of districts with MCV1 coverage >=95% From 0 to 100%   100    89     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100    103  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.